NEW YORK, Feb. 01, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Natural Health Trends Corp. (“Natural Health”) (NASDAQ:NHTC) between March 6, 2015 and January 12, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Central District of California. If you purchased or otherwise acquired Natural Health securities between March 6, 2015 and January 12, 2016, your rights may be affected by this action. To get more information go to: http://zlk.9nl.com/natural-health-trends-nhtc.
The complaint alleges that throughout the Class Period Defendants issued false and misleading statements to investors and/or failed to disclose that: (1) the operations of Natural Health Trends’ Chinese entity is not in compliance with applicable Chinese laws; and (2) as a result, Defendants’ statements about Natural Health Trends’ business, operations, and prospects, were false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in Natural Health you have until March 14, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/natural-health-trends-nhtc.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Shell M&A Chief Exits After BP Takeover Proposal Rejected 



